An additional 50 million performance shares will be issued to the vendor shareholders of MCL upon MCL obtaining a permit from the Australian Government to grow cannabis varieties for medical Cannabis research leading to product development. These performance shares will be subject to shareholder approval under Listing Rule 7.1 of the ASX Listing Rules.
